© 2001 by Oxford University Press
Journal of the National Cancer Institute Monographs, No. 29, 16-20,
2001
© 2001 Oxford University Press
Protection Against Mucosal Injury By Growth Factors and Cytokines
Affiliations of authors: Cancer Research Campaign Epithelial Biology Group, Paterson Institute for Cancer Research, Christie Hospital, Manchester, U.K.
Correspondence to: C. S. Potten, B.Sc., M.Sc, Ph.D., D.Sc., Epistem Ltd., Incubator Building, Grafton St., Manchester M13 9XX, U.K. (e-mail: cpotten{at}epistem.co.uk).
This article provides an overview of published studies in which growth factors and cytokines were used to modify the sensitivity of intestinal stem cells to a dose of radiation. In these experiments, growth factors were used to manipulate the sensitivity of stem cells in the gastrointestinal tract to reduce the severity of gastrointestinal mucositis in cancer therapy patients. Transforming growth factor
3, interleukin 11, and keratinocyte growth factor were used. All three agents, given according to appropriate protocols, can result in a threefold to fourfold increase in the number of intestinal stem cells that survive a dose of radiation therapy. This result was assessed by using the crypt microcolony assay of stem cell functional capacity. The changes in stem cell survival that were observed resulted in increased animal survival. This increased survival was taken as a surrogate for improvement in patient well-being. The severity of diarrhea, a marker of functional impairment, was concomitantly reduced.
This article has been cited by other articles:
![]() |
R. J. George, M. A. Sturmoski, R. May, S. M. Sureban, B. K. Dieckgraefe, S. Anant, and C. W. Houchen Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G245 - G254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boerma, J. Wang, A. F. Burnett, A. D. Santin, J. J. Roman, and M. Hauer-Jensen Local Administration of Interleukin-11 Ameliorates Intestinal Radiation Injury in Rats Cancer Res., October 1, 2007; 67(19): 9501 - 9506. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Blijlevens and S Sonis Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis Ann. Onc., May 1, 2007; 18(5): 817 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Muncan, O. J. Sansom, L. Tertoolen, T. J. Phesse, H. Begthel, E. Sancho, A. M. Cole, A. Gregorieff, I. M. de Alboran, H. Clevers, et al. Rapid Loss of Intestinal Crypts upon Conditional Deletion of the Wnt/Tcf-4 Target Gene c-Myc Mol. Cell. Biol., November 15, 2006; 26(22): 8418 - 8426. [Abstract] [Full Text] [PDF] |
||||



